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Editorial Commentary
Understanding the Power of Perinatal Events and
Metabolic Status in Childhood
Bonita Falkner, Julie Ingelfinger
See related article, p 1326–1332

O

ver the past 25 years, the concept that perinatal events
influence an individual’s later health and susceptibility
to disease has gained traction. After original observations by
Barker et al,1 epidemiological studies have identified a link
between markers such as lower birth weight and placental
weight with later cardiovascular, metabolic, and other diseases.
The theory of fetal programming in response to the intrauterine
environment has been supported by a body of elegant experimental investigations in animals. However, findings from clinical investigations in humans have not always been consistent,
and other factors such as weight gain trajectories and various
environmental exposures, such as diet, stress, and lifestyle
behaviors, also influence later health. Moreover, prospective
studies in humans that begin in the neonatal or even perinatal
period are limited. Ethical limitations in the conduct of clinical
research in newborn infants and young children are obvious,
and creative approaches are needed to prospectively investigate the birth weight hypothesis. In this issue of Hypertension,
Lurbe et al2 report on a study that provides new insights on
childhood origins of chronic disease.
The authors enrolled a sample of healthy newborn infants.
All enrolled infants were born at term after uncomplicated
pregnancies. The investigators stratified infants according to
birth weight (small [SGA], appropriate [AGA], or large for
gestational age [LGA]). Blood pressure (BP) was measured at
2 days of age. The infants were then re-examined at 6 months,
2 years, and 5 years. At each study visit, BP and growth
parameters were obtained. At age 5 years, a blood sample was
obtained for measurement of metabolic parameters.
Despite the relatively small sample size (n=139) of the
study, the results are very interesting. At birth, birth weight
and BP are positively related. Each birth weight group gained
similar amount of weight in each examination interval; the
SGA infants remained the smallest and the LGA infants
remained the largest at each subsequent examination. Weight
gain within the first 6 months of life was similar in each birth
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weight group and was not related to BP or subsequent metabolic parameters. After 6 months, both current weight and
weight gain were significantly and positively associated with
birth weight; birth weight was not significantly associated with
the BP level. Most interesting were the metabolic findings. As
depicted by the authors in Figure 1, fasting insulin levels are
higher in SGA infants who became heavy at age 5 years compared with AGA and LGA infants who become heavy at age
5 years. Most striking are the homeostatic model assessment
index estimates of insulin resistance. As shown in the figure,
SGA infants are insulin-resistant relative to AGA and LGA
infants, regardless of their weight status at age 5 years. These
findings, in a sample of healthy infants, indicate that one or
a combination of factors related to lower birth weight set the
stage for relative insulin resistance that is enduring and seems
not to be driven only by excess weight gain.
Earlier epidemiological studies reported a significant inverse
relationship between birth weight and subsequent BP, with
hypertension considered to be a major mediating link between
low birth weight and subsequent cardiovascular disease. Data
in the current report by Lurbe et al2 suggest that metabolic
variation may be a seminal mediating link as well. Regardless
of weight gain, by age 5 years the SGA group was insulinresistant with lower high-density lipoprotein-cholesterol and
higher uric acid levels, compared with the other birth weight
groups. Together, these relative metabolic differences suggest
that features of the metabolic syndrome are present early, with
the risk that high BP could possibly evolve as a consequence
of later adiposity.
Based on epidemiological associations between greater
body weight at 1 year of age and lower risk of later cardiovascular disease,3 nutritional augmentation to promote growth
was considered beneficial for SGA infants. Subsequent studies to test this idea reported that overnutrition in early infancy
was associated with later metabolic abnormalities4,5 and suggested that overnutrition with accelerated weight gain in the
first months of life contributed to adverse metabolic changes.
However, metabolic assessments in these studies were
obtained in later childhood4 or adolescence.5 Contrary to these
reports, Lurbe et al2 found that weight gain within the first 6
months had no effect on metabolic variations measured at age
5 years in SGA infants. Based on a systematic review of published evidence on the association of birth weight with type
2 diabetes mellitus in adults, Whincup et al6 reported that in
most populations birth weight was inversely related to type 2
diabetes mellitus. The report by Lurbe et al2 in this issue adds
novel findings on the low birth weight pathway to chronic disease with data demonstrating relative insulin resistance at age
5 years in SGA infants. Recently, in a cross-sectional study
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in Brazil, Crispim et al7 reported findings similar to those of
Lurbe et al,2 but their study was not prospective.
Other issues of interest in the authors’ study cohort include
the rather high rates of obesity at age 5 years. Fifty percent of
LGA newborns were obese at age 5 years, although this sample
was limited to 20 children. The obesity prevalence may reflect
the current childhood obesity epidemic but could also augment
some of the metabolic parameters that were studied. Absent are
data on maternal and perinatal parameters including maternal
weight, diet, social economic status, and other exposures, as
well as maternal weight postpartum. Such information would
permit multivariable analysis that might help control for additional factors that may have influenced the results.
In all, the results of the study by Lurbe et al2 suggest that
metabolic status in 5-year-old children born at term may be
influenced or programmed by perinatal events. A variety of
potential mechanisms have been considered to explain the
developmental origins of health and disease, such as changes
in the microarchitecture of various organs, changes in transporters or hormonal levels, and changes that involve epigenetic alterations. Epigenetic modification is a term that indicates
modifications in DNA without changes in the DNA sequence
per se. These changes may occur via methylation of cytosine
in CpG dinucleotides, by phosphorylation, and ADP ribosylation. Other possible changes include the ubiquitination of
histones and acetylation. Additionally, the function and conformation of chromatin can be altered by noncoding RNAs.
Epigenetic modification may alter the way by which transcription activators and repressors bind to the DNA. The type of
epigenetic change may influence the effects—although histone modifications of DNA have relatively short-term effects,
DNA methylation may lead to longer-term changes.
There are evolving theories as to how epigenetic changes
might influence programming of cardiovascular disease.
Although epigenetic changes may be reversible, some epigenetic modifications may be inherited. In other words, epigenetic
changes occur as part of the life cycle, but they also occur in
response to stress. Thus, the concept that a stressful perinatal
environment would potentially lead to epigenetic alterations
in the stressed fetus or newborn is attractive. Some of these
potential changes will affect the individual in later life, and
some might be passed on to future generations. Most epigenetic data with respect to perinatal programming are experimental,8 but some human data support the concept that intrauterine
stress leads to epigenetic change. For example, changes in the
patterns of DNA methylation of insulin-like growth factor 2
(IGF2DMR) have been noted in persons exposed to famine
conditions in utero.9 Indeed, the IGF2 and H19 loci have been
thought to influence birth weight and growth, though results
are conflicting.10 Bouwland-Both et al11 recently examined a

prospective birth cohort of SGA children in The Netherlands
and compared them to children who were AGA at term. The
authors extracted DNA from umbilical cord white blood cells,
examined DNA methylation, and observed that decreased DNA
methylation of IGF2DMR was present among SGA children.
Further epigenetic studies may be helpful to our interpretation of prospective studies such as Lurbe et al’s.2 One hopes
that banking of cord blood samples may allow comparisons of
physiological results to both genetic and epigenetic studies.
To understand the phenomenon of perinatal programming, it
will be necessary to take careful phenotypic observations such
as those of the current study and pair them with molecular
mechanisms. The molecular ability to do so is increasingly
available and has the potential to deepen our understanding
on fetal origins of chronic diseases such as hypertension and
diabetes mellitus.
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